FindTrial
Sign In

Linking neuroinflammation to Type 2 diabetes mellitus associated cognitive impairment and depression

Association of CaN/NFAT neuroinflammatory pathway with cognitive impairment and depression in Type 2 diabetes mellitus patients - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/07/090879
Enrollment
176
Registered
2025-07-14
Start date
Unknown
Completion date
Unknown
Last updated
2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E116- Type 2 diabetes mellitus with other specified complications

Interventions

Intervention1: Blood Sample Collection: A 5 mL venous blood sample was collected from each Type 2 Diabetes Mellitus (T2DM) patient using standard aseptic techniques. The samples were allowed to clot a

Sponsors

Dr Nidhi
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients suffering from T2DM as assessed through laboratory parameters such as HbA1c, RBS and FBS. Patients with low MMSE and MoCA scores and high HDRS and PHQ-9 scores

Exclusion criteria

Exclusion criteria: Pregnant or lactating females Patients of drug abuse or alcholism Patients suffering from infectious diseases

Design outcomes

Primary

MeasureTime frame
Baseline assessmentTimepoint: cross-sectional study—

Secondary

MeasureTime frame
NILTimepoint: NIL—

Countries

India

Contacts

Public ContactNikita gupta

Jamia Hamdard

nikitamittal314@gmail.com962569970

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Sep 19, 2026